Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation

Biochemical Pharmacology

Volumn 72, Issue 8, 2006, Pages 1022-1030

  Nieves, Diana ^a   Moreno, Juan José ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Apoptosis; Cell cycle; Cell growth; Leukotriene; Leukotriene receptor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (2,6 DIHYDROXYHEXYL) 6 (3 HYDROXY 1,5 UNDECADIENYL)PYRIDINE; 6 (4 CARBOXYPHENYLTHIO) 5 HYDROXY 7,9,11,14 ICOSATETRAENOIC ACID; ALPHA PENTYL 3 (2 QUINOLYLMETHOXY)BENZYL ALCOHOL; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; DNA; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; NORDIHYDROGUAIARETIC ACID; PEPTIDOLEUKOTRIENE; PHOSPHATIDYLINOSITOL 3 KINASE; STAUROSPORINE; THYMIDINE; TOMELUKAST; TRITIUM; VERLUKAST; WORTMANNIN; ZILEUTON;

ANIMAL CELL; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE ACTIVATED CELL SORTING; MACROPHAGE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; ARACHIDONATE 5-LIPOXYGENASE; CASPASES; CELL CYCLE; CELL LINE; CELL PROLIFERATION; DNA FRAGMENTATION; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE B4; LEUKOTRIENE D4; LIPOXYGENASE INHIBITORS; MACROPHAGES; MEMBRANE PROTEINS; MICE; RECEPTORS, LEUKOTRIENE; RECEPTORS, LEUKOTRIENE B4;

EID: 33748521513     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.07.021     Document Type: Article

References (47)

1. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
2. Bonney R.J., and Humes J.L. Physiological and pharmacological regulation of prostaglandin and leukotriene production by macrophages. J Leukocyte Biol 35 (1984) 1-10
3. Hong J., Bose M., Ju J., Ryu J.H., Chen X., Sang S., et al. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25 (2004) 1671-1679
4. Kawajiri H., Makino I., and Yoshimoto T. Intracellular activation and induction of 12-lipoxygenase in mouse peritoneal macrophages. Adv Exp Med Biol 507 (2002) 161-164
5. Christmas P., Fox J.W., Ursino S.R., and Soberman R.J. Differential localization of 5- and 15-lipoxygenases to the nuclear envelope in raw macrophages. J Biol Chem 274 (1999) 25594-25598
6. Tager A.M., and Luster A.D. BLT1 and BLT2: the leukotriene B4 receptors. Prostag Leukotr Ess Fatty Acids 69 (2003) 123-134
7. Lötzer K., Spanbroek R., Hildner M., Urbach A., Heller R., Bretschneider E., et al. Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis. Arterioscler Thromb Vasc Biol 23 (2003) E32-E36
8. Peppelenbosch M.P., Tertoolen L.G., Hage W.J., and de Laat S.W. Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell 74 (1993) 565-575
9. Fiorucci S., Lanfrancone L., Santucci L., Calabro A., Orsini B., Federico B., et al. Epidermal growth factor modulates pepsinogen secretion in guinea pig gastric chief cells. Gastroenterology 111 (1996) 945-958
10. Antoniotti S., Pla A.F., Pregnolato S., Mottola A., Lovisolo D., and Munaron L. Control of endothelial cell proliferation by calcium influx and arachidonic acid metabolism: a pharmacological approach. J Cell Physiol 197 (2003) 370-378
11. Tang D.G., and Honn K.V. Apoptosis of W256 carcinosarcoma cells of the monocytoid origin induced by NDGA involves lipid peroxidation and depletion of GSH: role of 12-lipoxygenase in regulating tumor cell survival. J Cell Physiol 172 (1997) 155-170
12. Ghosh J., and Myers C.E. Inhibition of arachidonic 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci USA 95 (1998) 13182-13187
13. Walker J.L., Loscalzo J., and Zhang Y.Y. 5-Lipoxygenase and human pulmonary artery endothelial cell proliferation. Am J Physiol: Heart Circ Physiol 282 (2002) H585-H593
14. McMahon B., Mitchell D., Shattock R., Martin F., Brady H.R., and Godson C. Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J 16 (2002) 1817-1819
15. Przylipiak A., Hafner J., Przylipiak J., Kohn F.M., Runnebaum B., and Rabe T. Influence of 5-lipoxygenase on in vitro growth of human mammary carcinoma cell line MCF-7. Gynecol Obstet Invest 46 (1998) 61-64
16. Nishizawa Y., Nishii K., Kishimoto S., Matsumoto K., and Sato B. Regulatory role of arachidonic acid-derived metabolites for proliferation of transformed murine Leydig cell in serum-free culture conditions. Anticancer Res 10 (1990) 317-322
17. Titos E., Clarià J., Planagumà A., López-Parra M., Villamar N., Párrizas M., et al. Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis. FASEB J 17 (2003) 1745-1747
18. Carter G.W., Young P.R., Albert D.H., Bouska J., Dyer R., Bell R.L., et al. 5-Lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther 256 (1991) 929-937
19. Tang D.G., Chen Y.Q., and Honn K.V. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc Natl Acad Sci USA 93 (1996) 5241-5246
20. Fleisch J.H., Rinkema L.E., Haisch K.D., Swanson-Bean D., Goodson T., Ho P.P., et al. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist. J Pharmacol Exp Ther 233 (1985) 148-157
21. Martin V., Sawyer N., Stocco R., Unett D., Lerner M.R., Abramovitz M., et al. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors. Biochem Pharmacol 62 (2001) 1193-1200
22. Yokomizo T., Kato K., Terawaki K., Izumi T., and Shimizu T. A second leukotriene B4 receptor, BLT2: a new therapeutic target in inflammation and immunological diseases. J Exp Med 192 (2000) 421-431
23. Musser J.H., Charkraborty U.R., Sciortino S., Gordon R.J., Khandwala A., Neiss E.S., et al. Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists. J Med Chem 30 (1987) 96-104
24. Nothacker H.P., Wang Z., Zhu Y., Reinscheid R.K., Lin S.H., and Civelli O. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. Mol Pharmacol 58 (2000) 1601-1608
25. Pang L., Sawada T., Decker S.J., and Saltiel A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270 (1995) 13585-13588
26. Powis G., Bonjouklian R., Berggren M.M., Gallegos A., Abraham R., Ashendel C., et al. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res 54 (1994) 2419-2423
27. Sanchez T., and Moreno J.J. Role of EP1 and EP4 PGE2 subtype receptors in serum-induced 3T6 fibroblast cycle progression and proliferation. Am J Physiol Cell Physiol 282 (2002) C280-C288
28. Lu M.C., Peters-Golden M., Hostetler D.E., Robinson N.E., and Derksen F.J. Age-related enhancement of 5-lipoxygenase metabolic capacity in cattle alveolar macrophages. Am J Physiol 271 (1996) L547-L554
29. Argentieri D.C., Ritchie D.M., Ferro M.P., Kirchner T., Wachter M.P., Anderson D.W., et al. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile. J Pharmacol Exp Ther 271 (1994) 1399-1408
30. Hope W.C., Welton A.F., Fiedler-Nagy C., Batula-Bernardo C., and Coffey J.W. In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin. Biochem Pharmacol 32 (1983) 367-371
31. Mikuni M., Yoshida M., Hellberg P., Peterson C.A., Edwin S.S., Bennstrom M., et al. The lipoxygenase inhibitor, nordihydroguaiaretic acid, inhibits ovulation and reduces leukotriene and prostaglandin levels in the rat ovary. Biol Reprod 58 (1998) 1211-1216
32. Agarwal R., Wang Z.Y., Bik D.P., and Mukhtar H. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes. Drug Metab Dispos 19 (1991) 620-624
33. Vargaftig B.B., and Singer M. Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am J Respir Cell Mol Biol 28 (2003) 410-419
34. Ogasawara H., Ishii S., Yokomizo T., Kakinuma T., Komine M., Tamaki K., et al. Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2. J Biol Chem 277 21 (2002) 18763-18768
35. Ciccarelli R., D'Alimonte I., Santavenere C., D'Auro M., Ballerini P., Nargi E., et al. Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via cys-LT1 receptors and mitogen-activated protein kinase pathway. Eur J Neurosci 20 (2004) 1514-1524
36. Tong W.G., Ding X.Z., Witt R.C., and Adrian T.E. Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Ther 1 (2002) 929-935
37. Porreca E., Di Febbo C., Di Sciullo A., Angelucci D., Nasuti M., Vitullo P., et al. Cysteinyl leukotriene D4 induced vascular smooth muscle cell proliferation: a possible role in myointimal hyperplasia. Thromb Haemostasis 76 (1996) 99-104
38. Romano M., Catalana A., Nutini M., D'Urbano E., Crescenzi C., Clarià J., et al. 5-Lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor. FASEB J 15 (2001) 2326-2336
39. Fujiwara T., Misumi Y., and Ikehara Y. Direct interaction of the Golgi membrane with the endoplasmic reticulum membrane caused by nordihydroguaiaretic acid. Biochem Biophys Res Commun 301 (2003) 927-933
40. 2+. Pharmacol Toxicol 89 (2001) 301-305
41. Seufferlein T., Seckl M.J., Schwarz E., Beil M., Wichert G., Baust H., et al. Mechanisms of nordihydroguaiaretic acid-induced growth inhibition and apoptosis in human cancer cells. Br J Cancer 86 (2002) 1188-1196
42. Panettieri R.A., Tan E.M.L., Ciocca V., Luttmann M.A., Leonard T.B., and Hay D.W.P. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol 19 (1998) 453-461
43. Paruchuri S., and Sjölander A. Leukotriene D4 mediates survival and proliferation via separate but parallel pathways in the human intestinal epithelial cell line Int 407. J Biol Chem 278 (2003) 45577-45585
44. Tong W.G., Ding X.Z., Hennig R., Witt R.C., Standop J., Pour P.M., et al. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Clin Cancer Res 8 (2002) 3232-3242
45. Klein J.B., Buridi A., Coxon P.Y., Rane M.J., Manning T., Kettritz R., et al. Role of extracellular signal-regulated linase and phosphatidylinositol-3 kinase in chemoattractant and LPS delay of constitutive neutrophil apoptosis. Cell Signal 13 (2001) 335-343
46. Paruchuri S., Hallberg B., Juhas M., Larsson C., and Sjolander A. Leukotriene D4 activates MAPK through a Ras-independent but PKCέ-dependent pathway in intestinal epithelial cells. J Cell Sci 115 (2002) 1883-1893
47. Paruchuri S., Broom O., Dib K., and Sjolander A. The pro-inflammatory mediator leukotriene D4 induces phosphatidylinositol 3-kinase and Rac-dependent migration of intestinal epithelial cells. J Biol Chem 280 (2005) 13538-13544